Dartmouth Events

Greetings!

Please join us on Wednesday, April 12 at noon on Zoom for a special seminarby Dr. Elaine Kuhn, a candidate for the T32 Quantitative Population Sciences in Cancer post-doctoral fellowship program at Geisel!

Seminar Title: “Prevention of metastatic breast cancer through improved adherence to adjuvant endocrine therapy"

This presentation will be recorded.

Join via Zoom:

URL: https://dartmouth.zoom.us/j/5037795102

Meeting room ID: 503-779-5102

Password: 6501974

Phone (if needed for mic audio only): 669-900-6833

Speaker Bio: Elaine Kuhn, MD, MS, is a first-year fellow in the Department of Hematology/Oncology at Dartmouth-Hitchcock Medical Center, where she also completed a residency in Internal Medicine. Prior to coming to Dartmouth, Dr. Kuhn was a medical student at Geisinger-Commonwealth School of Medicine in Scranton, PA. She earned a Master's of Science in Medical Sciences with a focus on breast and ovarian cancer at Boston University. Dr. Kuhn has a Bachelor's of Science in Biomedical Engineering from Rensselaer Polytechnic Institute. Her career interest is focused on breast oncology and survivorship.

Presentation Summary: In the genomic era, more women with low-risk breast cancer will forego chemotherapy and rely on adjuvant endocrine therapy (AET) alone to prevent metastatic recurrence. However, some of these patients will unfortunately relapse. In our preliminary work to understand this outcome, we found that nearly all cases of metastatic recurrence at our Cancer Center are due to non-adherence with AET. The most common reason for early discontinuation of AET is side effects. We therefore designed a clinical trial (the SWIVEL study) to evaluate and compare strategies for supporting breast cancer patients who struggle with side effects. In this seminar, I will provide the history of non-adherence to AET and literature to date, review our recent work, and conclude with the rationale and design of the SWIVEL Study – due to open at our Cancer Center in August 2023.